Autoimmune pancreatitis mimicking carcinoma of the head of the pancreas: a case report
© Ghadir et al; licensee BioMed Central Ltd. 2012
Received: 25 November 2010
Accepted: 11 January 2012
Published: 11 January 2012
We report on a case of autoimmune pancreatitis presenting as pancreatic head cancer, which is extremely rare in Iran. Currently, on the PubMed database, no such cases exist.
A 70-year-old Iranian man presented with recurrent abdominal pain, jaundice and elevated bilirubin and alkaline phosphatase levels. An abdominal computed tomography scan revealed a heterogeneous presence in the pancreatic head as well as dilated intra- and extrahepatic bile ducts. A common bile duct stent had been inserted. Our patient was subsequently diagnosed with pancreatic head cancer.
Due to his continued recurrent abdominal pain, our patient returned to the hospital. His levels of bilirubin, alkaline phosphatase and tumor markers were all normal but his immunoglobulin G4 and antinuclear antibodies were extremely high. A biopsy of the pancreatic head heterogeneity by endoscopic ultrasonography was performed.
Pathologic samples showed fibrosis associated with lymphoplasmacytic infiltration and no evidence of malignancy. A diagnosis of autoimmune pancreatitis was confirmed, the bile duct stent removed, and an appropriate treatment plan was undertaken.
Autoimmune pancreatitis should be considered in suspected cases of pancreatic cancer. In these instances, a biopsy of the pancreas will help to differentiate between the two and prevent complications due to disease progression as well as unnecessary surgery.
Autoimmune pancreatitis (AIP) is a rare disease and has only been reported in certain countries . Cases of autoimmune pancreatitis that mimic pancreatic head cancer are rare in Iran.
AIP is a primary pancreatic disorder that is associated with other autoimmune disorders, such as primary biliary cirrhosis, rheumatoid arthritis, sarcoidosis, inflammatory bowel disease and vitiligo . The disease commonly presents as recurrent mild abdominal pain with obstruction of the biliary ducts and pancreatic duct; there may be a pancreatic mass that can be misdiagnosed as pancreatic lymphoma or cancer . Although such cases are rare, an accurate diagnosis of AIP can prevent the progression of the disease and unnecessary surgery.
The diagnostic criteria defined by the Mayo Clinic include one or more of three characteristics: diagnostic histology; related features in abdominal magnetic resonance imaging (MRI) or computed tomography (CT) in association with increased levels of immunoglobulin G4 (IgG4); and the response of intra- or extrapancreatic manifestations to corticosteroid therapy .
The imaging features of the disease have similar presentations in both MRI and CT scans and may include local or diffuse enlargement of the pancreas . AIP can appear as a common bile duct stricture in an endoscopic retrograde cholangiopancreatography. It is impossible to distinguish AIP from pancreatic cancer solely by means of such imaging techniques .
A serum level of IgG4 above 135 ng/dL has very high sensitivity and specificity in differentiating AIP from pancreatic cancer . However, although increased serum levels of IgG4 and radiologic features associated with a therapeutic response to corticosteroids are suggestive of AIP, a pancreatic biopsy is essential in confirming the diagnosis. Histological findings in the pancreatic sample include dense fibrosis and inflammatory levels of lymphoplasmacytic infiltration .
The results of laboratory tests before the stent placement.
The laboratory test results after the stent placement.
White blood cell count
Mean corpuscular volume
Erythrocyte sedimentation rate
Blood urea nitrogen
Total iron binding capacity
Carbohydrate antigen 125
Carbohydrate antigen 19-9
2.5 ng/5 mL
Once AIP had been diagnosed, prednisolone was administered. Two months after treatment, a reevaluation of the pancreas head by means of an abdominal spiral CT scan with oral and venous contrast media did not show any abnormality, and the common bile duct stent was removed because of the positive therapeutic response.
The etiology of AIP, a rare type of chronic pancreatitis, has been recognized by clinical, histological and morphologic findings . Recently, it has been described as a systemic disease with lymphoplasmacytic infiltration that is associated with other autoimmune diseases. The disease has been reported in a number of countries and its incidence has been rising in some regions, especially in Japan [1, 6].
Typically, AIP can present in various clinical forms, including mild pancreatitis, acute recurrent pancreatitis, biliary duct strictures and pancreatitis, with such clinical presentations as primary sclerosing cholangitis and a pancreatic mass, which may be misdiagnosed as pancreatic cancer.
Acute AIP symptoms may also include rare, intermittent abdominal pain, weight loss, jaundice and an obstructive pattern of liver enzymes (an inappropriate rise of alkaline phosphatase relative to a mild elevation in aminotransferases) that may also be seen in cases of pancreatic cancer and cholangiocarcinoma .
AIP has been reported in two patients with obstructive jaundice and a diagnosis of pancreatic head cancer was made based on radiologic studies conducted by Japanese researchers . In another study, AIP was reported as the most common benign disease in patients with a diagnosis of pancreatic adenocarcinoma who had undergone a pancreatoduodenectomy .
The definitive diagnosis of AIP is made by radiologic CT scan findings of a narrowing of the pancreatic duct and parenchymal edema of the pancreas ; and on MRI as a focal or diffuse expansion of the pancreas (a sausage shape). These findings are usually associated with an absence of vascular marking, calcification or fluid collection around the pancreas, a narrowing of the main pancreatic duct and a crescent development of the pancreas head .
AIP is routinely responsive to corticosteroid therapy over a one to four month period . During treatment, patients typically have an immunological follow-up with an assessment of serum levels of IgG4 through a CT scan.
AIP is an autoimmune disease with varying diagnostic criteria, which include a range of pancreatic manifestations and specific MRI findings. A pancreatic biopsy, increased IgG4 serum level and a therapeutic response to corticosteroids are necessary in determining a definitive differentiation from a diagnosis of pancreatic adenocarcinoma based on radiologic findings . A precise diagnosis of AIP would prevent complications arising from the progression of the disease and unnecessary surgery [4, 10].
Written consent was obtained from the patient for publication of this case report and any accompanying images.
- Kim KP, Kim MH, Lee SS, Seo DW, Lee SK: Autoimmune pancreatitis: it may be a worldwide entity. Gastroenterology. 2004, 126 (4): 1214-View ArticlePubMedGoogle Scholar
- Kamisawa T, Egava N, Nakajima H: Autoimmune pancreatitis is a systemic autoimmune disease. Am J Gastroenterol. 2003, 98 (12): 2811-2812. 10.1111/j.1572-0241.2003.08758.x.View ArticlePubMedGoogle Scholar
- Garber t, Farrell TJ: Autoimmune pancreatitis: time for a single nomenclature (abstract). Gastroenterology. 2004, 126 (suppl 2): 255-Google Scholar
- Chari ST, Smyrk TC, Levy MJ, Topazian MD, Takahashi N, Zhang L, Clain JE, Pearson RK, Petersen BT, Vege SS, Farnell MB: Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol. 2006, 4 (8): 1010-1016. 10.1016/j.cgh.2006.05.017.View ArticlePubMedGoogle Scholar
- Eerens I, Vanbeckevoort D, Vansteenbergen W, Van Hoe L: Autoimmune pancreatitis associated with primary sclerosing cholangitis: MR imaging findings. Eur Radiol. 2001, 11 (8): 1401-1404. 10.1007/s003300000742.View ArticlePubMedGoogle Scholar
- Hyodo N, Hyodo T: Ultrasonographic evaluation in patients with autoimmune-related pancreatitis. J Gastroenterol. 2003, 38 (12): 1155-1161. 10.1007/s00535-003-1223-7.View ArticlePubMedGoogle Scholar
- Egawa N, Irie T, Tu Y, Kamisawa T: A case of autoimmune pancreatitis with initially negative auto antibodies turning positive during the clinical course. Dig Dis Sci. 2003, 48 (9): 1705-1708. 10.1023/A:1025426508414.View ArticlePubMedGoogle Scholar
- Varadarjulu S, Cotton PB: Autoimmune pancreatitis: is it relevant in the west?. Gastroenterology. 2003, 125 (5): 1557-View ArticleGoogle Scholar
- Servais A, Pestieau SR, Detry O, Honore P, Belaiche J, Boniver J, Jacquet N: Autoimmune pancreatitis mimicking cancer of the head of pancreas: report of two cases. Acta Gastroenterol Belg. 2001, 64 (2): 227-230.PubMedGoogle Scholar
- Gumbs AA, Kim J, Kiehna E, Brink JA, Salem RR: Autoimmune pancreatitis presenting as simultaneous masses in the pancreatic head and gallbladder. JOP. 2005, 6: 455-459.PubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.